Genome-wide screen in human plasma identifies multifaceted complement evasion of Pseudomonas aeruginosa

PLoS Pathog. 2023 Jan 25;19(1):e1011023. doi: 10.1371/journal.ppat.1011023. eCollection 2023 Jan.

Abstract

Pseudomonas aeruginosa, an opportunistic Gram-negative pathogen, is a leading cause of bacteremia with a high mortality rate. We recently reported that P. aeruginosa forms a persister-like sub-population of evaders in human plasma. Here, using a gain-of-function transposon sequencing (Tn-seq) screen in plasma, we identified and validated previously unknown factors affecting bacterial persistence in plasma. Among them, we identified a small periplasmic protein, named SrgA, whose expression leads to up to a 100-fold increase in resistance to killing. Additionally, mutants in pur and bio genes displayed higher tolerance and persistence, respectively. Analysis of several steps of the complement cascade and exposure to an outer-membrane-impermeable drug, nisin, suggested that the mutants impede membrane attack complex (MAC) activity per se. Electron microscopy combined with energy-dispersive X-ray spectroscopy (EDX) revealed the formation of polyphosphate (polyP) granules upon incubation in plasma of different size in purD and wild-type strains, implying the bacterial response to a stress signal. Indeed, inactivation of ppk genes encoding polyP-generating enzymes lead to significant elimination of persisting bacteria from plasma. Through this study, we shed light on a complex P. aeruginosa response to the plasma conditions and discovered the multifactorial origin of bacterial resilience to MAC-induced killing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Complement Membrane Attack Complex
  • Complement System Proteins
  • Humans
  • Pseudomonas aeruginosa* / genetics

Substances

  • Anti-Bacterial Agents
  • Complement System Proteins
  • Complement Membrane Attack Complex

Grants and funding

The work described in this paper was supported by grants from the French national agency for research (Agence Nationale de la Recherche; ANR-15-CE11-0018-01), the Laboratory of Excellence GRAL, funded through the University Grenoble Alpes graduate school (Écoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003), the Fondation pour la Recherche Médicale (Team FRM 2017, DEQ20170336705) to I.A., and the European Union's Horizon 2020 research programs H2020-EU-ITN-EJD (CORVOS No #860044 to F.M. and S.H.M.R.). This work availed of the platforms at the Grenoble Instruct-ERIC center (ISBG; UAR 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-0005- 02) and GRAL, funded through the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003). S.P, J.T and M.JM were recipients of Ph.D. fellowships from the French Ministry of Education and Research. S.S received the Master 2 GRAL fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.